Skip to content

Clinical trials

Phase 2 Frailty trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Frailty Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20132
20162
20185
20212
20222
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Suspended2
Terminated2
Enrolling by invitation2
Recruiting2
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic4
National Institute on Aging (NIA)2
University of Rochester2
Anne B. Newman1
Bijan Najafi, PhD1
Gladwin, Mark, MD1
Johns Hopkins University1
Massachusetts General Hospital1
National Institute of Allergy and Infectious Diseases (NIAID)1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Frailty21
Inflammation7
Sarcopenia5
Diabetes Mellitus2
Neoplasms2
Renal Insufficiency, Chronic2
Anemia1
Arthritis1
Cognitive Dysfunction1
Diabetic Nephropathies1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.